Novo Nordisk | NVO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
ANI Pharmaceuticals USD 1.88B 133M 2026-06
Aurora Cannabis CAD 193.82M 133.39M 2026-03
Bausch Health Companies USD 2.61B 200M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Canopy Growth CAD 557.13M 99.33M 2026-03
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Drreddys Laboratories INR 11.07B 619M 2026-03
Eli Lilly USD 1.13T 260.54B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Merck USD 317.37B 20.27B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Novartis USD 240.59B 67.17B 2026-06
Novo Nordisk DKK 212.17B 55.02B 2026-06
Novo Nordisk A/S DKK 1.4T 373.76B 2026-06
Pacira USD 998M 83M 2026-06
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.24B 566M 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Supernus Pharmaceuticals USD 2.7B 277M 2026-06
Zoetis USD 30.13B 19.58B 2026-06